⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propionic Acid SCHEMBL3795566 | 0.92 | — | — | |
| Propionic Acid SCHEMBL5054297 | 0.92 | FFAR3 (0.77) | — | |
| Propionic Acid SCHEMBL27616282 | 0.89 | FFAR3 (0.71) | — | |
| Propionic Acid SCHEMBL28226878 | 0.89 | FFAR3 (0.71) | — | |
| Propionic Acid SCHEMBL28408085 | 0.89 | FFAR3 (0.71) | — | |
| Propionic Acid SCHEMBL27617722 | 0.89 | — | — | |
| Propionic Acid SCHEMBL4808475 | 0.88 | — | — | |
| Propionic Acid SCHEMBL7091617 | 0.88 | — | — | |
| Propionic Acid SCHEMBL6308852 | 0.88 | FFAR3 (0.83) | — | |
| Propionic Acid SCHEMBL28348475 | 0.88 | FFAR3 (0.83) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112930175-A | Method for treating epilepsy | 泽农医药公司 | 2021-06-08 | — | — | CN | disclosed |
| EP-2496262-A2 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | Université de Genève (CH) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011051916-A2 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | UNIVERSITE DE GENEVE (CH) | 2011-05-05 | — | — | WO | disclosed |